Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02537730
Other study ID # CVJ-EX-MKTG-1318
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2015
Est. completion date June 2016

Study information

Verified date August 2020
Source Coopervision, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Two week, Open Label, randomized, bilateral, crossover, 1 week of daily wear in each combination (lens / disinfecting cleaning system).


Description:

To determine if patients are unreactive to the lens care solution / Biofinity combination. It is expected that there will be a total of three visits: V1 (Initial), V2 (1 week), & V3 (2 weeks).


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date June 2016
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Is over 18 years of age (inclusive)

- Has had a self-reported visual exam in the last two years

- Has a CL (contact lens) spherical prescription between -0.25D (Diopters) and -12.00D (inclusive)

- Has less than 1.00 D spectacle cylinder in each eye

- Is correctable to a visual acuity of 20/20 or better in both eyes

- Has clear corneas and no active ocular disease

- Has read, understood and signed the informed consent letter

- Is willing to comply with the wear schedule (at least 40hrs per week)

- Is willing to comply with the visit schedule

Exclusion Criteria:

- Has never worn contact lenses before

- Currently wears rigid gas permeable contact lens

- Has a history of not achieving comfortable CL (contact lens) wear (5 days per week; > 8 hours per day)

- Has a CL prescription outside the range of -0.25D to -12.00D

- Has a spectacle cylinder greater than -0.75D of cylinder in either eye

- Has best corrected spectacle distant vision worse than 20/20 in ether eye

- Has any systemic disease affecting ocular health

- Is using any systemic or topical medications that will affect ocular health

- Has any ocular pathology or sever insufficiency of lacrimal secretion

- Has persistent, clinically significant corneal or conjunctival staining

- Has active neovascularization or any central corneal scars

- Is aphakic

- Is pregnant or lactating

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Bioclean MPS VII
PHMB (Polyhexamethylene biguanide) base Disinfecting and Cleaning system
Aosept Clearcare
Hydrogen Peroxide Disinfecting and Cleaning system
comfilcon A
contact lens

Locations

Country Name City State
Japan Kodama Eye Clinic Joyo-shi Kyoto-fu
Japan Higashihara Eye Clinic Kameoka Kyoto-fu
Japan Iwasaki Eye Clinic Osaka-shi Osaka-fu

Sponsors (1)

Lead Sponsor Collaborator
Coopervision, Inc.

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ocular Health - Corneal Staining Corneal staining for Bioclean MPS (Multi-Purpose Solution) VII / comfilcon A combination and Aosept Clearcare / comfilcon A combination assessed by slit lamp. Grade 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe. 1 week
Secondary Comfort Subjective ratings of comfort scores for Bioclean MPS VII / comfilcon A combination and Aosept Clearcare / comfilcon A combination were assessed at 1 week: after insertion, after 4 hours of wear, after 8 hours of wear, before removal, and after all day wear. Scale 0-10, 0=very bad/poor, 10=very good/excellent. 1 week
Secondary Dryness Subjective ratings of dryness for Bioclean MPS VII / comfilcon A combination and Aosept Clearcare / comfilcon A combination were assessed at 1 week: after insertion, after 4 hours of wear, after 8 hours of wear, before removal, and after all day wear. Scale 0-10, 0=very bad/poor, 10=very good/excellent. 1 week
Secondary Stinging and Burning Sensation Subjective ratings of stinging and burning sensation for Bioclean MPS VII / comfilcon A combination and Aosept Clearcare / comfilcon A combination. Scale 0-10, 0=difficult to wear, 10=no sensation at all. Baseline
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A